Background. Metabolic Syndrome (MetS) is a prevalent cluster of conditions that significantly increases the risk of cardiovascular disease and type 2 diabetes mellitus. Lifestyle modification is universally recognized as the primary therapeutic strategy, with aerobic exercise playing a crucial role in improving metabolic health and reducing mortality risks in affected populations. Aim. This review synthesizes current evidence on the efficacy and mechanisms of aerobic exercise as a fundamental non-pharmacological strategy for managing Metabolic Syndrome (MetS). Material and methods. A search of major databases (2015–2025) was performed, focusing on systematic reviews and RCTs. Keywords included "Metabolic Syndrome," "aerobic exercise," "insulin resistance," "dyslipidemia," and "exercise prescription." Results. Regular aerobic exercise improves cardiometabolic risk factors independently of significant weight loss. It enhances insulin sensitivity via GLUT4 translocation, optimizes the lipid profile (reducing triglycerides, increasing HDL), and reduces visceral adiposity and inflammation. Additionally, High-Intensity Interval Training (HIIT) is highlighted as a potent strategy, often offering superior efficacy to moderate-intensity continuous training (MICT). Conclusions. Aerobic exercise is an essential component of MetS management. Professionals should prioritize individualized prescriptions, incorporating both MICT and HIIT, to effectively mitigate cardiometabolic risk and improve patient health.
6 January 2026 in International Journal of Innovative Technologies in Social Science
The dawn phenomenon (DP), defined as an early-morning rise in glucose unrelated to preceding nocturnal hypoglycemia, represents a significant yet often underrecognized contributor to fasting hyperglycemia and overall glycemic instability in individuals with diabetes. The expansion of continuous glucose monitoring (CGM) technologies over the past decade has enabled more precise characterization of nocturnal glucose patterns, offering new insights into the prevalence, magnitude, and clinical implications of DP across diverse glycemic states. This review synthesizes original observational, retrospective, and prospective studies published between 2010 and 2025 that used CGM to evaluate DP in type 1 diabetes, type 2 diabetes, impaired glucose tolerance, and non-diabetic populations. Data extraction focused on DP definitions, nocturnal glucose trajectories, glycemic variability metrics, associations with HbA1c and time-in-range, and emerging evidence linking severe DP to adverse clinical outcomes. Findings indicate that DP is highly prevalent in both type 1 and type 2 diabetes, with magnitude varying widely depending on residual β-cell function, insulin sensitivity, and methodological differences in CGM-based definitions. DP correlates with increased total glucose exposure and greater glycemic variability, and may influence long-term metabolic risk. Understanding DP within the context of CGM-derived metrics is essential for optimizing individualized therapeutic strategies and improving morning glycemic control. Further standardized research is required to unify definitions and clarify the prognostic significance of DP.
6 January 2026 in International Journal of Innovative Technologies in Social Science
The rapid digitalization of health care, propelled by the COVID-19 pandemic, has led to a rapidly growing gap in use of medical technology for senior patients. The inclusion of wearable medical devices, patient portals, telemedicine, and access to information has created an opportunity for patients to have more control over their health than ever before. However, for elderly patients it also comes with new challenges due to fear or reluctance to use advanced technologies they are not familiar with, leaving them to rely on family members and caregivers. It was found that health care provider’s hesitation in offering digital options and the expenses associated with digital devices are another obstacle. There is a significant need for modification in health care personnel attitudes regarding technology, promotion of combining community centers and health care for improving overall quality of life and digital literacy, and advocacy for senior patients' opinions when creating new medical technology and possibly incorporating AI technology to aid in bridging the gap.
Background. Cardiac rehabilitation plays a crucial role in reducing mortality and improving the quality of life in patients after cardiovascular events. High-intensity interval training (HIIT) is gaining attention as a time-efficient and potentially more effective alternative to moderate-intensity continuous training (MICT). Aim. The aim of this review is to assess the effectiveness and the safety of high-intensity interval training in cardiac rehabilitation. Material and methods. A literature search was performed using PubMed database, narrowing it down to studies published between 2015 and 2025. The inclusion criteria focused on the use of high-intensity interval training in patients with coronary artery disease, after myocardial infarction, and with heart failure. Results. The analyzed studies demonstrated that high-intensity interval training significantly improves cardiorespiratory fitness, endothelial function, and metabolic parameters. Recent meta-analyses confirm the effectiveness of HIIT showing a significantly greater increase in peak oxygen uptake (VO₂ peak), with an average difference of approximately 1.42 mL/kg/min, compared to MICT. When patients are properly selected and monitored, HIIT is safe and well tolerated in cardiac rehabilitation programs. Conclusions. HIIT is an effective and safe form of exercise for cardiac patients and may complement or even replace traditional training approaches. However, it requires individualized programming and supervision by a specialized medical team. Further research is necessary to confirm its long-term outcomes.
Background. Non-suicidal self-injury (NSSI) occurs in 69-90% of women with borderline personality disorder (BPD) and represents a critical diagnostic criterion and therapeutic challenge. Despite its high prevalence and clinical significance, the dynamic psychological and neurobiological mechanisms underlying NSSI remain incompletely understood, and a substantial gap persists between acute symptom reduction and long-term psychosocial recovery. Aim. This study reviews NSSI in BPD, focusing on: identification of proximal psychological mechanisms and developmental factors influencing NSSI risk, and assessment of specialized therapeutic approaches' effectiveness in reducing NSSI and achieving sustained psychosocial functioning. Materials and Methods. A literature review was conducted using databases (PubMed, PsycINFO, and Google Scholar) for articles up to November 2025. Inclusion criteria focused on peer-reviewed studies examining NSSI in BPD populations using validated assessment tools. Results. Neuroimaging demonstrates that NSSI produces immediate amygdala deactivation, providing neurobiological reinforcement for this behavior. The Emotional Cascade Model identifies rumination instability and emotion differentiation deficits as key triggers for NSSI episodes. Childhood trauma dysregulates the HPA axis and correlates with functional deficits. Dialectical Behavior Therapy (DBT) shows a moderate effect size in reducing self-harm (Hedges' g = -0.622) and induces neuroplastic changes. Mentalization-Based Therapy (MBT) reduces suicide attempts, though social functioning often remains impaired even in long-term follow-up. Conclusions. Specialized psychotherapies effectively stabilize acute symptoms, but a clear gap persists between symptom control and functional recovery. Future research should adopt complex dynamic systems perspectives and prioritize outcomes reflecting social integration and quality of life.
17 January 2026 in Journal of Education, Health and Sport
Background. Lipedema is a chronic and progressive fat disorder that affects ~11% of the female population. It is characterized by bilateral, disproportionate accumulation of subcutaneous adipose tissue predominantly in the lower body. Symptoms include pain, bruising, swelling, and subcutaneous nodules that are resistant to traditional interventions such as diet and exercise. Aim. The objective of this review is to summarize recent evidence on the characteristics, pathophysiology, diagnosis and treatment of lipedema. Matherial and Methods. A literature search was conducted using the PubMed database. The inclusion criteria were “full free text” and English scientific articles, published between 2015 and 2025. A total of 74 records were found, of which publications were ultimately included in the review. Results. Awareness of lipedema in the medical field is increasing, but its differential diagnosis still remains a challenge. Lipedema is often unrecognized or misdiagnosed as obesity or lymphedema. Conclusion. This narrative review provides a deeper understanding of lipedema as a serious condition, discusses its pathophysiology and treatment options. The data reveal advances in knowledge, particularly in conservative and surgical treatment with a focus on improving quality of life. However, there is a lack of scientific evidence confirming the safety and efficacy of various treatment methods. Further research is required to ensure the safety and increase the efficacy of treatment for this complex condition known as lipedema.